http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107998113-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107998113-B |
| titleOfInvention | Application of flavonoid compound CH625 in preparation of anti-glioma drugs |
| abstract | The invention discloses an application of a flavonoid compound CH625 in preparation of an anti-glioma drug. Belongs to the field of medicine technology. According to the invention, on the basis of building a glioma model, the in vivo anti-tumor effect of CH625 is researched by experimental methods such as immunofluorescence, Western blot and flow cytometry, and the result shows that the anti-glioma angiogenesis effect of CH625 is achieved by inhibiting the activity of CYP4X1 and inducing blood vessels to be normalized. The preparation method of the CH625 is very pure, the CH625 monomer with higher purity and excellent quality can be obtained through natural extraction or chemical synthesis, and has the advantages of no toxic or side effect on human bodies, quick drug effect, no irritation, safe use and good effect. |
| priorityDate | 2018-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 346.